Author: IQ TIMES MEDIA
Anthropic is attracting an increasing number of supporters in its fight against the U.S. Department of Defense, which last month designated the AI lab as a supply-chain risk after it refused to make concessions on how its AI could be used by the military. In a letter to Defense Secretary Pete Hegseth, U.S. Senator Elizabeth Warren (D-MA) equated the DoD’s decision with “retaliation,” arguing that the Pentagon could simply have terminated its contract with the AI lab, CNBC reports. “I am particularly concerned that the DoD is trying to strong-arm American companies into providing the Department with the tools to…
Fusion startup Helion is reportedly in talks to sell power to OpenAI. Both companies are backed by Sam Altman. The deal, which was reported by Axios, is in early stages, and it could guarantee OpenAI 12.5% of Helion’s production — five gigawatts by 2030 and 50 gigawatts by 2035. OpenAI partner Microsoft signed a similar deal with Helion in 2023 to buy power starting in 2028. If the figures in Axios’ report prove to be accurate, it suggests that Helion expects to be able to rapidly scale production of its fusion power plant. Helion has said that each of its…
OpenAI CEO Sam Altman is stepping down as board chair of the Helion — the fusion startup he backs — amid reported talks between the two companies. The deal, which was reported by Axios, is in early stages, and it could guarantee OpenAI 12.5% of Helion’s production — five gigawatts by 2030 and 50 gigawatts by 2035. OpenAI partner Microsoft signed a similar deal with Helion in 2023 to buy power starting in 2028. If the figures in Axios’ report prove to be accurate, it suggests that Helion expects to be able to rapidly scale production of its fusion power…
March 31, 2026, marks 50 years since a landmark decision that shapes American patients’ rights every day: the New Jersey Supreme Court ruling in the case of Karen Ann Quinlan, who had suffered an irreversible coma.Quinlan’s case established for the first time that decisions near the end of life should be made by patients and families, not by doctors and hospitals alone. As a bioethicist, I have taught and written extensively about the profound impact the Quinlan case has had on law, bioethics and the pursuit of death with dignity.The Quinlan storyIn April 1975, at the age of 21, Karen…
Your back pain gets worse as you sit through a long meeting. Your wrist pain flares when you’re typing furiously to meet a tight deadline. During a busy shift at the grocery store, you feel a migraine coming on.If that sounds familiar, you’ve got plenty of company. About 1 in 4 U.S. adults suffer from chronic pain. The share who say they are in chronic pain either on most days or every day in the past three months is growing: It jumped by nearly 4 percentage points to 23% of U.S. adults in 2023, up from 19% in 2019.Chronic pain…
Last Easter while my children were sorting through their baskets of chocolate eggs and jelly beans, my son looked up from the table and asked a simple question:“Why don’t Grandma and Grandpa eat candy like we do?”It was the kind of question children ask without really thinking. To him, it seemed obvious: Candy is delicious, so why wouldn’t everyone want it?From a child’s perspective, it can look like older adults simply lose their taste for sweets. But as a speech-language pathologist who studies swallowing disorders, I know the explanation is often more complicated. In many cases, the issue has less…
Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. Ever notice how nutrition advice keeps changing?Yeah, don’t answer that.I’ve been writing about how our diet affects our health for longer than I care to calculate. I’ve watched low-fat come and go. I’ve watched low-carb morph to paleo, and then keto, and then carnivore. I’ve watched people eat according to their blood type or food’s pH. And now we’re saddled with dietary guidelines that double down on meat, saturated fat and protein.Nobody can get a straight answer to the simple question: What should…
Whether they’re using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to lose weight and boost health.About 1 in 8 U.S. adults say they are taking a GLP-1 drug, according to a recent survey by the health research group KFF.Just since January, more than 600,000 prescriptions have been written for Novo Nordisk’s new Wegovy pill, the company said. Early analysis suggests that more than a third of users are new to the drugs, according to Truveta, a health care data company.But medication alone isn’t the answer, experts caution. It also takes lifestyle changes —…
And then there were four.The first round of voting for our business-focused March Madness bracket is done. We’re on to the final four.Thanks to all those who participated, as we got more than 300 votes. Clearly, some of you had an issue with the selection committee — me — because the favorites got decimated.A quick recap, I identified and seeded eight of the top business trends this year. Each week, readers vote for the topics that matter most to them.Let’s get to the results: Every time Dan publishes a story, you’ll get an alert straight to your inbox! Stay connected…
For some tech CEOs, they’re not just building AI — they’re already living with it. Loading audio narration… Three founders of AI startups in San Francisco shared with Business Insider how they personally use AI in their work and lives, and what some of their favorite tools are for themselves and their team members.From running diagnostics on complex cloud systems to drafting proposals on a time crunch, here is how AI is helping these CEOs keep up with their busy schedules.Vipul Ved PrakashVipul Ved Prakash, the cofounder and CEO of Together AI, which enables developers to train generative AI models,…